Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors

Overview of attention for article published in Journal of the American Pharmaceutical Association, September 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#44 of 2,205)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 7 news outlets
patent: 5 patents

reddit: 1 Redditor

Readers on

mendeley: 139 Mendeley

So far, Altmetric has seen 7 news stories from 7 outlets.

Ozempic in the spotlight is just the latest in the long, strange history of weight-loss drugs - galaxyconcerns

Galaxy Concerns, 31 Aug 2023

Losing weight conveniently, cheaply, safely. That’s been the holy grail of weight-loss ever since 19th century English…

Ozempic in the spotlight is just the latest in the long, strange history of weight-loss drugs

Salon, 31 Aug 2023

Losing weight conveniently, cheaply, safely. That's been the holy grail of weight-loss ever since 19th century English…

Ozempic is in the spotlight but it’s just the latest in a long and strange history of weight loss drugs

Wheels24, 22 Aug 2023

Losing weight conveniently, cheaply, safely. That’s been the holy grail of weight-loss ever since 19th century English…

Ozempic is in the spotlight, but it's just the latest in a long and strange history of weight-loss drugs

MedicalXpress, 09 Aug 2023

Losing weight conveniently, cheaply, safely. That's been the holy grail of weight-loss ever since 19th century English…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.